Cresset Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-71,605
Closed -$1.12M 1945
2024
Q3
$1.12M Sell
71,605
-7,583
-10% -$119K ﹤0.01% 1084
2024
Q2
$1.36M Buy
79,188
+40,139
+103% +$688K 0.01% 879
2024
Q1
$610K Buy
39,049
+19,010
+95% +$297K ﹤0.01% 1219
2023
Q4
$299K Buy
+20,039
New +$299K ﹤0.01% 1468